|
EIF2AK4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.693990E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.374600E-01 |
| Normal-vs-Stage2 |
9.177400E-01 |
| Normal-vs-Stage3 |
4.160100E-02 |
| Normal-vs-Stage4 |
2.595600E-03 |
| Stage1-vs-Stage2 |
7.170600E-01 |
| Stage1-vs-Stage3 |
5.455500E-02 |
| Stage1-vs-Stage4 |
6.663400E-03 |
| Stage2-vs-Stage3 |
1.176780E-01 |
| Stage2-vs-Stage4 |
1.622090E-02 |
| Stage3-vs-Stage4 |
2.625600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.725200E-01 |
| Normal-vs-AfricanAmerican |
6.016800E-01 |
| Normal-vs-Asian |
2.743600E-01 |
| Caucasian-vs-AfricanAmerican |
7.733200E-01 |
| Caucasian-vs-Asian |
9.632600E-01 |
| AfricanAmerican-vs-Asian |
7.560800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.925600E-01 |
| Normal-vs-Female |
1.627160E-01 |
| Male-vs-Female |
2.606400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.547000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.681600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.662170E-01 |
| Normal-vs-Age(81-100Yrs) |
2.772400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.920200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.811600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.882000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.740600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.537200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.642400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.154500E-02 |
| Classical-VS-Follicular |
3.026800E-01 |
| Classical-VS-Other |
3.965800E-01 |
| Classical-VS-Normal |
3.660200E-01 |
| Tall-VS-Follicular |
3.940600E-03 |
| Tall-VS-Other |
7.094000E-01 |
| Tall-VS-Normal |
3.824200E-03 |
| Follicular-VS-Other |
3.005000E-01 |
| Follicular-VS-Normal |
9.593000E-01 |
| Other-VS-Normal |
1.736610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.837000E-01 |
| Normal-vs-N1 |
5.078100E-03 |
| N0-vs-N1 |
4.378000E-02 |
|
|
